Future targets for migraine treatment beyond CGRP

Future targets for migraine treatment beyond CGRP

Abstract Background Migraine is a disabling and chronic neurovascular headache disorder. Trigeminal vascular activation and release of calcitonin gene-related peptide (CGRP) play a pivotal role in the pathogenesis of migraine. This knowledge has led to the development of CGRP(-receptor) therapies. Y...

Full description

Bibliographic Details
Main Authors: Linda Al-Hassany, Deirdre M. Boucherie, Hannah Creeney, Ruben W. A. van Drie, Fatemeh Farham, Silvia Favaretto, Cédric Gollion, Lou Grangeon, Hannah Lyons, Karol Marschollek, Dilara Onan, Umberto Pensato, Emily Stanyer, Marta Waliszewska-Prosół, Wietse Wiels, Hui Zhou Chen, Faisal Mohammad Amin, on behalf of the European Headache Federation School of Advanced Studies (EHF-SAS)
Format: Article
Language:English
Published: BMC 2023-06-01
Series:The Journal of Headache and Pain
Subjects:
Migraine
Non-CGRP targets
Pituitary adenylate cyclase-activating polypeptide
Vasoactive intestinal polypeptide
Amylin
Adrenomedullin
Online Access:https://doi.org/10.1186/s10194-023-01567-4

Internet

https://doi.org/10.1186/s10194-023-01567-4

Similar Items